Stay updated with breaking news from Dan Bloomfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases,...
The FDA has granted Fast Track designation to abelacimab for the treatment of thrombosis associated with cancer.
Abelacimab: First Factor XI Inhibitor to Enroll Patients in a Phase 3 Clinical Trial - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...